KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on May 29, 2026 >>  ABB India 7229.6  [ 0.17% ]  ACC 1398.85  [ -2.02% ]  Ambuja Cements 448  [ -2.62% ]  Asian Paints 2672.1  [ -0.01% ]  Axis Bank 1287.9  [ -1.19% ]  Bajaj Auto 10460.45  [ -3.24% ]  Bank of Baroda 268.55  [ -0.92% ]  Bharti Airtel 1829.7  [ -1.16% ]  Bharat Heavy 416.55  [ -1.43% ]  Bharat Petroleum 297.5  [ -3.11% ]  Britannia Industries 5193.15  [ -2.67% ]  Cipla 1398.5  [ -1.39% ]  Coal India 457.6  [ -1.14% ]  Colgate Palm 2060.3  [ -1.29% ]  Dabur India 443.6  [ -0.39% ]  DLF 592.15  [ -0.39% ]  Dr. Reddy's Lab. 1302.95  [ -1.22% ]  GAIL (India) 164.3  [ -2.78% ]  Grasim Industries 3120.35  [ -1.55% ]  HCL Technologies 1184.35  [ 1.65% ]  HDFC Bank 744.75  [ -1.81% ]  Hero MotoCorp 4898.4  [ -3.47% ]  Hindustan Unilever 2145.95  [ -2.36% ]  Hindalco Industries 1126.6  [ -1.99% ]  ICICI Bank 1256  [ -1.32% ]  Indian Hotels Co. 655.15  [ -1.86% ]  IndusInd Bank 913.95  [ -2.01% ]  Infosys 1159.75  [ 0.05% ]  ITC 287  [ -1.71% ]  Jindal Steel 1205.75  [ -1.16% ]  Kotak Mahindra Bank 384.7  [ -0.94% ]  L&T 4076.65  [ 0.76% ]  Lupin 2272.45  [ -0.19% ]  Mahi. & Mahi 3034.8  [ -2.72% ]  Maruti Suzuki India 13119.85  [ -1.84% ]  MTNL 30.25  [ -2.29% ]  Nestle India 1422.85  [ -0.32% ]  NIIT 68.14  [ 0.28% ]  NMDC 87.9  [ -4.74% ]  NTPC 386.75  [ -2.86% ]  ONGC 266  [ -2.90% ]  Punj. NationlBak 106.05  [ -0.56% ]  Power Grid Corpn. 289.75  [ -3.46% ]  Reliance Industries 1320.55  [ -2.18% ]  SBI 964  [ -0.38% ]  Vedanta 352.65  [ -0.55% ]  Shipping Corpn. 292.9  [ -3.48% ]  Sun Pharmaceutical 1800.9  [ -2.39% ]  Tata Chemicals 758.2  [ -2.08% ]  Tata Consumer 1179.35  [ -2.12% ]  Tata Motors Passenge 393.25  [ -1.87% ]  Tata Steel 208.9  [ -2.72% ]  Tata Power Co. 420.65  [ -1.28% ]  Tata Consult. Serv. 2253.9  [ -1.19% ]  Tech Mahindra 1483.2  [ 1.96% ]  UltraTech Cement 11449.3  [ -2.07% ]  United Spirits 1270.75  [ -2.40% ]  Wipro 204.2  [ 1.29% ]  Zee Entertainment 93.26  [ 1.98% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

SUPRIYA LIFESCIENCE LTD.

29 May 2026 | 12:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE07RO01027 BSE Code / NSE Code 543434 / SUPRIYA Book Value (Rs.) 140.59 Face Value 2.00
Bookclosure 05/09/2025 52Week High 969 EPS 25.98 P/E 37.28
Market Cap. 7796.37 Cr. 52Week Low 546 P/BV / Div Yield (%) 6.89 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
The Company was incorporated as `Supriya Lifescience Limited' pursuant to a certificate of incorporation dated March 26, 2008 issued by the Registrar of Companies, Maharashtra at Mumbai ("RoC"), upon the conversion of `M/s Supriya Chemicals', a partnership firm, into a public limited company, in accordance with the provisions of Part IX of the Companies Act, 1956. the Company commenced operations pursuant to a certificate for commencement of business dated April 1, 2008 issued by the RoC.

Major events and milestones of the Company :
2008
- Incorporation of the Company upon its conversion from a partnership firm to a public limited company

2009
- Started production of Ketamine Hydrochloride

2010
- CEP (Certificate of Sustainability) granted for Chlorphenamine Maleate

2011
- IDL granted for Chlorphenamine Maleate

2013
- COFEPRIS and KFDA approval granted

2014
- USFDA approval granted
- IDL granted for Brompheniramine Maleate

2015
- EUGMP and EDQM approval granted

2017
- CEP (Certificate of Sustainability) granted for Pheniramine Maleate
- Second time USFDA approval granted

2018
- CEP (Certificate of Sustainability) granted for Brompheniramine Maleate, Mepyramine Maleate & Ketamine Hydrochloride

2020
- Third time USFDA approval

2021
- CEP (Certificate of Suitability) granted for Pentoxifylline, Esketamine Hydrochloride and Salbutamol Sulphate
- NMPA approval granted
- Health Canada approval

2022
-Supriya Lifescience Limited has informed the Exchange regarding 'Intimation Regarding Captive Solar Project Agreement Signed with Enrich Energy Pvt. Ltd'.

2024
-"Supriya Lifescience Ltd Inaugurates State-of-the-Art Module E Production Block at Lote Parshuram, Maharashtra". -Supriya Lifescience inaugurates Rs 125 crore API production block at Lote Parshuram site.

2025
-Supriya Lifescience honoured with Maharashtra State Export Award for two consecutive years
-Supriya Lifescience Secures WHO GMP Certification for Ambernath Facility